LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 72 filers reported holding LEAP THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 23 | -88.9% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 208 | -79.2% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 1,000 | -0.6% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 1,006 | -50.2% | 0.00% | – |
| Q2 2021 | $3,000 | -25.0% | 2,019 | +0.1% | 0.00% | – |
| Q1 2021 | $4,000 | – | 2,016 | +12500.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 16 | -96.7% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 492 | +28.1% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 384 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 384 | +10.0% | 0.00% | – |
| Q3 2019 | $0 | – | 349 | +2584.6% | 0.00% | – |
| Q2 2019 | $0 | – | 13 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 13 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 13 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 13 | -90.4% | 0.00% | – |
| Q4 2017 | $1,000 | – | 136 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 16,952,992 | $27,802,000 | 0.18% |
| Opaleye Management Inc. | 540,000 | $886,000 | 0.15% |
| ACT CAPITAL MANAGEMENT, LLC | 134,000 | $220,000 | 0.11% |
| Artal Group S.A. | 3,000,000 | $4,920,000 | 0.10% |
| HHLR ADVISORS, LTD. | 3,575,745 | $5,864,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 910,047 | $1,492,000 | 0.04% |
| PERSONAL CFO SOLUTIONS, LLC | 78,165 | $128,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 122,401 | $201,000 | 0.02% |
| Windsor Creek Advisors, LLC | 46,955 | $77,000 | 0.02% |
| Golden Green, Inc. | 14,824 | $24,000 | 0.02% |